Five-fluorouracil (5-FU), an inhibitor of thymidylate synthase, was an early drug for several cancer treatments [23,24,25] and remains widely utilized in laboratory investigations to explore cancer cell adaptation mechanisms to drugs. This evidence concerns the gene TYMS and cancer.